DiaMedica Therapeutics Inc. (DMAC)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
7. 30
+0.17
+2.3843%
$
400.35M Market Cap
- P/E Ratio
- Div Yield
199,800 Volume
-0.72 Eps
$ 7.13
Previous Close 
Want to track DMAC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
DMAC Earnings Reports FAQ
What is the earnings per share (EPS) for DMAC?
The current EPS is -0.72.
What is the company's earnings growth rate?
DiaMedica Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
DiaMedica Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for DiaMedica Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for DMAC at this time, as DiaMedica Therapeutics Inc has no recent EPS data to calculate it.
